Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

: SUbstrate Ablation in Persistent Atrial Fibrillation for Elimination of Recurrences (SUPAFER): a Multicentre Randomized Clinical Trial to Assess Pulmonary Vein Isolation Alone or Combined With Linear Ablation.

NCT06291506 is registered in ClinicalTrials.gov with Hospital Universitario La Paz as lead sponsor.

NCT NCT06291506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06291506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
: SUbstrate Ablation in Persistent Atrial Fibrillation for Elimination of Recurrences (SUPAFER): a Multicentre Randomized Clinical Trial to Assess Pulmonary Vein Isolation Alone or Combined With Linear Ablation.
Lead sponsor
Hospital Universitario La Paz
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2023
Completion date
May 1, 2026
Enrollment
176 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation ablation, daily transtelephonic electrocardiogram, linear left atrial ablation, persistent and long lasting or chronic atrial fibrillation